In its most general sense, the term 'aminoglycoside' refers to any carbohydrate containing an amino-function and linked via the C-1 oxygen to a second moiety-the aglycone. In the field of antibiotics, however, the term is restricted in its use to those compounds in which the aglycone is a cyclitol or an aminocyclitol. The clinically important aminoglycosides fall into three 'families' exemplified by Streptomycin (I), neomycin (II) and kanamycin A (III) . In Streptomycin the aglycone is streptamine; in the other two cases In general the aminoglyeosides are broad-speetrum antibioties of major applieation in the treatment of Gram-negative infeetions. In partieular, the high poteney of some of the pseudotrisaeeharides 1 • 2 of the kanamyein group versus Pseudomonas organisms has been responsible for their relatively widespread use in both topieal and life-threatening systemie infeetions; e.g. a eumulative in vitro tube dilution study 3 of Garamycin® is shown in Table 1 . It ean be seen that at 10 J.lgfml-a therapeutieally attainable blood 
compounds have been determined 8 • 9 . The nomenclature of the sugar units is shown in (IV); the common sugar unit has been named garosamine and the dissimilar 2,6-diamino sugars have been named purpurosamine A, B and C corresponding to gentamieins C 1 , C 2 and C 13 respectively. It should also be noted that one literature report 10 has referred to 'gentamicin D' instead of gentamiein C 1 a. The former term is incorrect and the generally accepted nomenclature-gentamicin C 1 a will be used throughout this and subsequent publieations.
The gentamiein C components were separated by column chromatography on silica gel using the lower phase of the system chloroform-isopropanolammonia (1: 2: 1, developer), (1: 1: 1, eluent). This task was performed using two 5' x 4" glass columns (designed and built by 'Glenco,' Houston, Texas). linked in series and having all-Teflon® end plates and connections. The columns were wet-packed in the developing solvent system and were run at a constant flow rate of approximately 40-80 mljmin using an all-Teflon® metering pump. In this way approximately 750 g of gentamiein could be separated into its components. The structure studies will not be presented here in detail. It is, however, instructive to examine examples of some of the procedures used, especially where they relate to aminoglycoside structure determination in general.
Methanolysis of the C gentamicins 8 • 9 in methanolic hydrochloric acid gave the gentamines (V) and an anomeric mixture of methyl garosaminide 457 (VI). Cleavage of the purpurosamine sugar does not occur under these conditions; protonation of the 2-amino group prevents hydrolytic cleavage of the glycosidic linkage 11 . The reaction is thus diagnostic for the presence of a
2-amino-substituted sugar. The gentamines and methyl garosaminide were separated as free bases by a chromatographic procedure analogaus to the gentamiein separation method. Methyl garosaminide was a syrupy mixture of anomers separable by fractional crystallization of the N-acetyl-derivative and subsequent deacetylation with hydrazine. Analytical data and mass spectrometry established the molecular formula tobe C 8 H 17 N0 4 • Periodate oxidation sturlies showed that methyl garosaminide consumed two equivalents of periodate; the N-acetyl-derivative consumed none, a result in agreement with the structural formulation. N.m.r. analysis ofthe anomerically pure species 8 agreed unequivocally with the structure assignment and. further, confirmed the conformation of the molecule in solution. Application of Reeves' cuprammonium procedure 12 to methyl garosaminide showed a change in molecular rotation of -748°, a result most compatible with the L-arabino stereochemistry although not completely excluding the D-xylo configuration. Examination of the behaviour of the model compounds (VII) and (VIII) toward benzaldehyde showed that (VII} reacted exothermically in ethanol to give the epimeric oxazolidines (IX). Compound (VIII) did not react even on heating with neat benzaldehyde. Methyl garosaminide reacted with benzaldehyde exothermically and stereospecifically to give the crystalline oxazolidine (X); the n.m.r. spectrum of this compound (Figure 1 ) indicated little change in conformation, in agreement with the postulated cis-condensation of the oxazolidine ring.
The gentamines (V) were characterized by micro-analysis and mass spectrometry of their crystalline tetra-N-acetyl derivatives. Degradation by mercaptolysis using ethanethiol and aqueous hydrochloric acid afforded a quantitative yield of N,N'-diacetyl-2-deoxystreptamine, readily separable from the crystalline, chloroformsoluble purpurosamine derivatives (XIa, b, c). The mass spectra of these compounds were characteristic for derivatives of 2-N-aeetyl sugar thioaeetals 13 • Cantirrnation of the struetural assignments was obtained by analysis of the n.m.r. speetra (e.g. the purpurosamine B derivative, ·Figure 2) in whieh eritieal assignments were verified by double irradiation studies.
The stereoehemistry of 2-deoxystreptamine in the gentamines has been investigated by Dr R. D. Gutbrie et al. at the University of Sussex, Brighton, England. The eireular diehroism of the tetra-N-aeetyl gentamines in euprammonium solution showed a positive maximum at 570 IDil and a negative minimum at 280 m~ e6mpatible with a K ehelate 9 • 14 and thus a negative dihedral angle between the free hydroxyl groups of the 2-deoxystreptamine moiety, confirming the stereoehemistry shown in (V).
The point of attaehment of garosamine to 2-deoxystreptamine was aseertained by methylation of the gentamiein per-N-aeetyl derivatives using sodium hydride and methyl iodide in dimethylformamide followed by aeid hydrolysis to give N,N'-diaeetyl-N,N'-5-0-trimethyl-2-deoxystreptamine (XII), eonfirming the attaehment of garosamine to C-6 of the 2-deoxystreptamine unit. The strueture of (XII) was indieated by its laek of optical aetivity. However, the n.m.r. speetra in d 6 -DMSO was eomplex due to restrieted rotation about the -N-C-band. That this was the ease was
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Me 0 shown by re-running the speetrum at an elevated temperature whereupon it simplified to that expeeted for the symmetrieal (XII). In terms of stereoehemistry and disposition of amino-groups the gentamieins are closely analogaus to the kanamyeins 15 . A eonsiderable body of Iiterature has now been assembled on the kanamyeins and the gentamieins as we11 as some information on the related nebramyein antibioties 2 • An analysis of struetureaetivity and to some degree strueture-toxieity relationships is now possible. Table 2 illustrates the variation of antibaeterial aetivity with position of amino-groups, the stereochemistry remaining eonstant. The eompound (XIIIa) eontaining no amino-groups is inaetive. Introduetion of aminogroups at the 6,6' -positions (XIIIb) resulted in measurable aetivity, but only when the kanamyein C eonfiguration (XIIIe) is reaehed, with amino-groups in the 3 and 2' positions, does aetivity beeome good. Introduetion of an additional amino-group in the 3' -position of kanamyein A results in low aetivity. Optimal aetivity appears to be reaehed for kanamyein B (XIIIf) and tobramyein (XIIIh), both of whieh eontain a 2',6'-diaminosugar and a 3-aminosugar. The latter eonfiguration is also eommon to the C gentamieins (IV) all of which possess high l1road-speetrum antibiotie aetivity. The generalization ean be made that in eonsidering synthesis of new aminoglyeosides the tive amino-group eonfiguration of the known highly aetive eompounds will 461 probably be neeessary for optimal aetivity. With regard to stereoehemistry, little data have thus far been aceumulated. The strueture-toxieity relationships in the kanamyein series are somewhat less available. In general, the eompounds eontaining only four aminogroups (kanamyein A, kanamyein C) are eonsiderably less toxie than those containing five amino-groups 1 • 16 (kana myein B, tobramyein, gentamiein C). However, they arealso very mueh less aetive and the therapeutie ratios for e.g. gentamiein C are mueh more favourable than those of e.g. kanamycins A and C. On this point hinges the mueh greater clinieal versatility of the gentamicins. Published data 2 suggest that tobramyein may be less ototoxie than gentamiein although the experimental eonditions used by the Eli Lilly group were not in any way eomparable to those used by Waitz et al. 17 for the gentamieins. An ever increasing problern in aminoglycoside therapy is likely to be posed by the incidence of resistance mediated by R factors 18 . Thus far two such R factors are known to affect the kanamycin group and can be exemplified by reference to kanamycin A (XIV). One factor biologically inactivates the molecule by phosphorylation of the vacant 3-hydroxyl-group 19 giving (XV). The other factor results in acetylation of the 6'-amino-group (XVI) 20 again with biological inactivation. The in vitro action of these two R factors in the kanamycin series has been extensively examined by Dr Julian Davies and his associates at the University of Wisconsin. Their results are summarized in Table 3 . In general in the kanamycin series compounds having a free 3-0H group are phosphorylated and those having a 6-amino-group are acetylated, in both cases with resulting biological inactivation. The gentamiein C components, however, differ. No phosphorylation occurs because of the absence of a 3-0H group (this is also true of tobramycin). Acetylation occurs completely only in the case of gentamiein C 1 a. Gentamiein C 2 acetylates poorly and C 1 not at all. Presumably the latter two compounds offer steric hindrance to the acetylating enzyme. Interestingly, acetylation of gentamiein C la does not completely destroy its biologieal activity and it remains a moderately active antibiotic. It is evident that these unique features of the C gentamieins offer a significant clinical advantage over the other members of the kanamycin family. Our studies on the gentamieins have included not only those of established clinical importance but also many of the co-produced compounds contained in the gentamiein A/B complex 21 . Some of these compounds have been purified and their structures investigated; one of them, gentamiein A (XVII), was initially studied by Dr Carl Schaffner and his associates at Rutgers University and a gross structure was established 22 . Stereochemistry of the 3-deoxy-3-methylamino fragment (XVIII) was established by the Sehering group by total synthesis and was reported at the 158th National Meeting of the American Chemica] Society in September 1969 23 . The same synthesis was reported by the Rutgers group in early 1970 in a paper submitted on 6 September 1969 10 . Figure 3 summarizes the work performed at Sehering including the synthesis of the arabino-compound (XIX) mentioned earlier in relation to the establishment of the stereochemistry of garosamine. The crystalline and stable ketoepoxide (XX) is interesting in that it represents a new type of sugar intermediate.
The goal of our extensive investigations of structure-activity relationships in the gentamiein series was to develop knowledge that, combined with the available literature, would enable us to ernhark on a programme of semisynthetic and, perhaps, synthetic aminoglycosides designed to minimize nitrosochlorodimers (XXII) that will react readily with alcohols 30 • 31 (including very bindered alcohols) in dichloromethane or dimethylformamide to give the 2-oximino-a-glycoside (XXIII) in high yield. The product can be converted to the 2-aminosugar (XXIV) by hydrogenation or to the 2-hydroxycompound (XXV) via borohydride reduction of the ketose. Lemieux has demonstrated 30 the applicability ofthe method to the synthesis ofkanamycinlike antibiotics from 2-deoxystreptamine in yields approaching commercial interest. Total synthesis of kanamycin itself by the Lemieux procedure awaits the development of synthetic methods for the as yet undescribed 3-amino-or potentially 3-aminoglucals.
It seems likely that in the future we can look forward to semi-synthetic gentamieins into which considerable variation has been incorporated. lt 465 may weil be that this group of antibiotics stands now in the position occupied by penicillin at the time of isolation of 6-AP A. In any event the era of second generation aminoglycosides is now with us and if sufficient separation of toxicity and activity can be attained, they may well become the broad spectrum antibiotics of choice. Available evidence suggests that gentamiein is already making inroads into the markets formerly dominated by ß-lactams and tetracycline. The increasing problern of resistance to the latter compounds and the excellent resistance-profile of gentamiein and some of the related aminoglycosides are further telling arguments for the active development of these compounds as therapeutic agents.
